JNJ

Significant stock events for Johnson & Johnson are likely influenced by announcements of successful or unsuccessful clinical trial outcomes and regulatory approvals for new pharmaceutical drugs or medical devices. Strategic acquisitions or divestitures in the Innovative Medicine or MedTech segments, quarterly and annual earnings reports, and progress or setbacks in ongoing litigation, particularly related to product liability, can also significantly impact stock price. News regarding patent expirations for key drugs and the entry of biosimilar competitors can create downward pressure, while broader macroeconomic factors, interest rate changes, and healthcare policy shifts also influence JNJ's stock performance.